Loss per Share - Antidilutive securities (Details) - shares |
1 Months Ended | 3 Months Ended | 12 Months Ended | |
|---|---|---|---|---|
Dec. 31, 2021 |
Mar. 31, 2023 |
Mar. 31, 2022 |
Dec. 31, 2022 |
|
| Loss per Share | ||||
| Anti-dilutive securities | 212,844 | 218,707,000 | 214,978,000 | 216,622 |
| Stock warrants | ||||
| Loss per Share | ||||
| Anti-dilutive securities | 10,819 | 11,248,000 | 10,819,000 | 11,248 |
| Stock options | ||||
| Loss per Share | ||||
| Anti-dilutive securities | 5,487,000 | 2,134,000 | 3,402 | |
| Shares of Class V common stock | ||||
| Loss per Share | ||||
| Anti-dilutive securities | 202,025 | 201,972 | ||
| X | ||||||||||
- Definition Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|